This medication was FDA-approved for weight loss in 2023, and studies have shown that participants lost an average of 35.5 pounds after 72 weeks of taking the medication at its lowest dose, with the average amount of weight loss getting higher as the dosage increases
References Booth GL, Kapral MK, Fung K, Tu JV: Recent trends in cardiovascular complications among men and women with and without diabetes
117,118,119,120 Recent advancements have introduced novel biomarkers and advanced imaging techniques to enhance early detection
[11] Gadaleta MN, Petruzzella V, Renis M, Fracasso F, Cantatore P.Eur J Biochem
Customers are responsible for arranging and paying for express return shipping to SpectraCell Laboratories using FedEx International Priority express or an equivalent express courier service